Childs John W
- SEC CIK
- 0001027035
In the past year, 3 open-market purchase filings worth $30.9M and 1 sale filing worth $10.7M.
Current role at each company
- MANE Veradermics, IncDirectoras of Aug 14, 2026
- BHVN Biohaven Ltd.Directoras of Apr 30, 2026
- Biohaven Pharmaceutical Holding Co Ltd.Directoras of Oct 3, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $30.9M
- 3 filings
- Sold
- $10.7M
- 1 filing
- Net
- +$20.2M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Childs John W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MANE Veradermics, Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 (view filing) | Feb 5 | 22 days | Childs John WDirector | PPurchase | +294.1K | $17.00 | +$5.00M | New position294.1K after | Amended |
| Aug 14, 2026 (view filing)6:01 PM ET | Aug 12 | 2 days | Childs John WDirector | SSale | −100.0K | $107.12 | −$10.7M | −34.0%194.1K after | 3 lots |
BHVN Biohaven Ltd.
Director15 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2022 (view filing) | Oct 5 | Same day | Childs John WDirector | PPurchase | +274.1K | $8.98 | +$2.46M | +18.1%1.79M after | 2 lots |
| Mar 22, 2023 (view filing) | Oct 25, 2022 | 148 days | Childs John WDirector | PPurchase | +3.71M | $10.50 | +$39.0M | New position1.83M after | Amended2 lots |
| Aug 7, 2023 (view filing) | Aug 4 | 3 days | Childs John WDirector | PPurchase | +100.0K | $19.78 | +$1.98M | +5.5%1.93M after | |
| Aug 31, 2023 (view filing) | Aug 30 | 1 day | Childs John WDirector | PPurchase | +50.0K | $18.44 | +$922.0K | +2.6%1.98M after | |
| Oct 10, 2023 (view filing) | Oct 5 | 5 days | Childs John WDirector | PPurchase | +454.5K | $22.00 | +$10.0M | +27.4%2.11M after | 2 lots |
| Apr 23, 2024 (view filing) | Apr 22 | 1 day | Childs John WDirector | PPurchase | +122.0K | $41.00 | +$5.00M | +3.1%4.10M after | From original2 lots |
| May 14, 2024 (view filing) | May 13 | 1 day | Childs John WDirector | PPurchase | +28.5K | $35.17 | +$1.00M | +1.3%2.28M after | |
| May 31, 2024 (view filing) | May 30 | 1 day | Childs John WDirector | PPurchase | +28.0K | $35.58 | +$996.2K | +1.2%2.31M after | |
| Jul 19, 2024 (view filing) | Jul 18 | 1 day | Childs John WDirector | PPurchase | +28.4K | $35.67 | +$1.01M | +1.2%2.34M after | |
| Oct 3, 2024 (view filing) | Oct 2 | 1 day | Childs John WDirector | PPurchase | +21.1K | $47.50 | +$1.00M | New position21.1K after |
Biohaven Pharmaceutical Holding Co Ltd.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2021 (view filing) | Nov 10 | Same day | Childs John WDirector | PPurchase | +5.00K | $122.87 | +$614.4K | +0.2%2.55M after | 2 lots |